| 2026-06-08 01:00:00 |
Roche Announces Global Collaboration With Nurix Therapeutics To Co-develop And Co-commercialise Potential Best-in-class Btk Degrader Bexobrutideg Across Malignant Haematology, Immunology And Neurology
Agreement offers potential best-in-class targeted protein degrader therapy option for people living with b-cell malignancies collaboration adds to roche’s oncology pipeline and offers potential indications in immunology (chronic spontaneous urticaria) and neurology (multiple sclerosis) bexobrutideg utilises a novel approach to eliminate the bruton’s tyrosine kinase (btk) protein, potentially overcoming existing resistance mechanisms found with current standard-of-care btk inhibitors basel, 08 june 2026 - roche (six: ro, rop; otcqx: rhhby) announced today that it has entered into an exclusive licensing and collaboration agreement with nurix therapeutics, inc. (nasdaq: nrix). under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialise bexobrutideg (nx-5948), nurix’s investigational bruton’s tyrosine kinase (btk) degrader. |
| 2026-06-04 11:33:00 |
Roche Rapidly Develops A Pcr Test For Ebola Within Six Days As Rare Bundibugyo Virus Drives Urgent Need For Detection
New roche test targeting detection of bundibugyo virus supports efforts to address critical need during ongoing outbreaks 1 roche’s unique outbreak response capabilities enabled rapid development of the pcr test within six days of the bundibugyo genome sequence being published this assay enables laboratories to swiftly establish testing capabilities, helping to contain the outbreaks while providing critical surveillance to monitor any further spread berlin, june 4, 2026 /prnewswire/ -- roche (six: ro, rop; otcqx: rhhby) announced today that it developed a research use only (ruo) molecular pcr test, via its subsidiary tib molbiol, for use on the lightcycler® 480 i & ii systems, lightcycler® pro system and the cobas® z 480 analyzer to detect the rare ebola bundibugyo virus. developed within just six days as part of its outbreak preparedness and surveillance expertise, this test supports response efforts in central and east africa and helps address critical needs identified during the ongoing outbreak. |
| 2026-06-03 06:00:00 |
Ideaya Biosciences Announces Clinical Collaboration With Roche In Mtap-deleted Ras-mutant Pancreatic Cancer
Ideaya entered into a clinical collaboration with roche to evaluate ide892, ideaya’s potential best-in-class phase 1 mta-cooperative prmt5 inhibitor, in combination with rg6505, roche’s phase 1 pan-ras inhibitor, in mtap-deleted, ras-mutant pancreatic ductal adenocarcinoma ideaya will sponsor the clinical trial, and there will be joint ideaya and roche governance to oversee the study mtap-deletion is estimated to occur in up to 40% of pdac south san francisco, calif., june 3, 2026 /prnewswire/ -- ideaya biosciences, inc. (nasdaq: idya), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced it has entered into a clinical collaboration with roche to evaluate the efficacy and safety of ide892, its investigational, potential best-in-class prmt5 inhibitor, in combination with roche’s rg6505, a pan-ras inhibitor, in patients with pancreatic ductal adenocarcinoma (pdac) that carry an mtap deletion. |
| 2026-06-02 01:05:00 |
Fda Accepts New Drug Application For Genentech’s Giredestrant In Er-positive Early-stage Breast Cancer, The First And Only Oral Serd With Positive Phase Iii Results In The Curative Setting
South san francisco, calif.--(business wire)---- $rhhby--fda accepts nda for genentech’s giredestrant in er+ early-stage breast cancer. |
| 2026-06-02 01:00:00 |
Fda Accepts New Drug Application For Roche’s Giredestrant In Er-positive Early-stage Breast Cancer, The First And Only Oral Serd With Positive Phase Iii Results In The Curative Setting
Filing acceptance, under priority review, based on phase iii data showing giredestrant reduced the risk of invasive disease recurrence or death by 30% compared with standard-of-care endocrine therapy1giredestrant represents the first significant advance in adjuvant endocrine therapy in over 20 years1-3giredestrant has the potential to become a new standard-of-care in the adjuvant setting; more than 90% of er-positive breast cancer cases are diagnosed at an early-stage (i-iii)4-7the fda has set a prescription drug user fee act date of 30 november 2026 basel, 02 june 2026 - roche (six: ro, rop; otcqx: rhhby) announced today that the united states (us) food and drug administration (fda) has accepted the company’s new drug application (nda) under priority review for giredestrant, an investigational oral selective oestrogen receptor degrader (serd), as an adjuvant treatment for adults with oestrogen receptor (er)-positive, human epidermal growth factor receptor 2 (her2)-negative, stage i, ii, and iii breast cancer. |
| 2026-06-01 01:00:00 |
Um9jaGUgVG 8gUHJlc2Vu dCBOZXcgRG F0YSBBZHZh bmNpbmcgSX RzIE9iZXNp dHkgUG9ydG ZvbGlvIEF0 IFRoZSBBbW VyaWNhbiBE aWFiZXRlcy BBc3NvY2lh dGlvbuKAmX MgMjAyNiBT Y2llbnRpZm ljIFNlc3Np b25z
TGF0ZS1icm Vha2luZyBw aGFzZSBpaS BkYXRhIGhp Z2hsaWdodC BlbmljZXBh dGlkZeKAmX MgKGN0LTM4 OCkgZWZmaW NhY3kgYW5k IHNhZmV0eS wgcmVpbmZv cmNpbmcgaX RzIHBvdGVu dGlhbCB0by BkZWxpdmVy IGJlc3QtaW 4tY2xhc3Mg d2VpZ2h0IG xvc3MgYWNy b3NzIGEgYn JvYWQgcG9w dWxhdGlvbi BvZiBwZW9w bGUgbGl2aW 5nIHdpdGgg b3ZlcndlaW dodCBvciBv YmVzaXR5bG F0ZS1icmVh a2luZyBkYX RhIGZyb20g dGhlIHBoYX NlIGlpIHp1 cHJlbWUtMS B0cmlhbCBz aG93Y2FzZS BwZXRyZWxp bnRpZGXigJ lzIGVmZmlj YWN5LCBzYW ZldHksIGFu ZCBjb21wZW xsaW5nIHRv bGVyYWJpbG l0eSBwcm9m aWxlLCB3aG ljaCBoYXMg dGhlIHBvdG VudGlhbCB0 byByZWRlZm luZSB0aGUg d2VpZ2h0IG 1hbmFnZW1l bnQgZXhwZX JpZW5jZSBm b3IgcGVvcG xlIGxpdmlu ZyB3aXRoIG 92ZXJ3ZWln aHQgb3Igb2 Jlc2l0eWEg cGhhc2UgaW kgbXVsdGkt YXJtIHRyaW FsIGV2YWx1 YXRpbmcgZW 5pY2VwYXRp ZGUgYW5kIH BldHJlbGlu dGlkZSBmaX hlZC1kb3Nl IGNvbWJpbm F0aW9ucyB3 aWxsIGJlIG luaXRpYXRl ZCB0b3dhcm RzIG1pZC0y MDI2IHRvIG RldmVsb3Ag YSBkaWZmZX JlbnRpYXRl ZCB0cmVhdG 1lbnQgb3B0 aW9uIGJhc2 VsLCAxIGp1 bmUgMjAyNi AtIHJvY2hl IChzaXg6IH JvLCByb3A7 IG90Y3F4Oi ByaGhieSkg YW5ub3VuY2 VkIHRvZGF5 IHRoYXQgbm V3IGRhdGEg ZnJvbSBpdH Mgb2Jlc2l0 eSBwb3J0Zm 9saW8gd2ls bCBiZSBwcm VzZW50ZWQg YXQgdGhlID IwMjYgc2Np ZW50aWZpYy BzZXNzaW9u cyBvZiB0aG UgYW1lcmlj YW4gZGlhYm V0ZXMgYXNz b2NpYXRpb2 4gKGFkYSku
|
| 2026-05-19 01:05:00 |
R2VuZW50ZW NoIFRvIFBy ZXNlbnQgTm V3IERhdGEg QXQgQXNjby AyMDI2LCBS ZWluZm9yY2 luZyBHaXJl ZGVzdHJhbn TigJlzIFBv dGVudGlhbC BUbyBUcmFu c2Zvcm0gVG hlIFRyZWF0 bWVudCBQYX JhZGlnbSBJ biBFYXJseS BCcmVhc3Qg Q2FuY2Vy
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb3 A7IG90Y3F4 OiByaGhieS ksIHdpbGwg cHJlc2VudC BuZXcgZGF0 YSBmcm9tIG 5pbmUgYXBw cm92ZWQgYW 5kIGludmVz dGlnYXRpb2 5hbCBtZWRp Y2luZXMgYW Nyb3NzIG1v cmUgdGhhbi AxNSBpbmRp Y2F0aW9ucy BhdCB0aGUg MjAyNiBhbW VyaWNhbiBz b2NpZXR5IG 9mIGNsaW5p Y2FsIG9uY2 9sb2d5IChh c2NvKSBhbm 51YWwgbWVl dGluZywgaG VsZCBtYXkg MjkgdG8gan VuZSAyIGlu IGNoaWNhZ2 8uIOKAmWdl bmVudGVjaO KAmXMgYXNj byBkYXRhIH JlZmxlY3Qg b3VyIGNvbW 1pdG1lbnQg dG8gYWRkcm Vzc2luZyB0 aG9zZSBjYW 5jZXJzIHRo YXQgaW1wb3 NlIHRoZSBo aWdoZXN0IG J1cmRlbiBv biBwYXRpZW 50cyBhbmQg c29jaWV0eS zigJkgc2Fp ZCBsZXZpIG dhcnJhd2F5 LCBtLmQuLC BwaC5kLiwg Y2hpZWYgbW VkaS4=
|
| 2026-05-19 01:00:00 |
Um9jaGUgVG 8gUHJlc2Vu dCBOZXcgRG F0YSBBdCBB c2NvIDIwMj YsIFJlaW5m b3JjaW5nIE dpcmVkZXN0 cmFudOKAmX MgUG90ZW50 aWFsIFRvIF RyYW5zZm9y bSBUaGUgVH JlYXRtZW50 IFBhcmFkaW dtIEluIEVh cmx5IEJyZW FzdCBDYW5j ZXI=
TmV3IGdpcm VkZXN0cmFu dCBkYXRhIG Zyb20gdGhl IGxpZGVyYS BzdHVkeSBv biBpdHMgcG 90ZW50aWFs IGFzIGEgbm V3IHN0YW5k YXJkIG9mIG NhcmUgZm9y IGFkanV2YW 50IGVyLXBv c2l0aXZlIG JyZWFzdCBj YW5jZXIgYW Nyb3NzIGFs bCBtZW5vcG F1c2FsIHN0 YWdlcyBwcm ltYXJ5IHJl c3VsdHMgZn JvbSB0aGUg cGVyc2V2ZX JhIHN0dWR5 IG9uIHRoZS BudW1lcmlj YWwgaW1wcm 92ZW1lbnQg aW4gcHJvZ3 Jlc3Npb24t ZnJlZSBzdX J2aXZhbCBv YnNlcnZlZC B3aXRoIGZp cnN0LWxpbm UgZ2lyZWRl c3RyYW50IH BsdXMgcGFs Ym9jaWNsaW IgaW4gYWR2 YW5jZWQsIG VuZG9jcmlu ZS1zZW5zaX RpdmUgZGlz ZWFzZW92ZX JhbGwsIG5p bmUgYXBwcm 92ZWQgYW5k IGludmVzdG lnYXRpb25h bCBtZWRpY2 luZXMsIGlu Y2x1ZGluZy BiaXNwZWNp ZmljIGFudG lib2RpZXMs IGFudGlib2 R5LWRydWcg Y29uanVnYX RlcyBhbmQg YnJhaW4tcG VybWVhYmxl IG1vbGVjdW xlcywgd2l0 aCBhc2NvIG RhdGEgdGFy Z2V0aW5nIH VyZ2VudCBu ZWVkcyBpbi BicmVhc3Qs IGJsb29kLC BsdW5nIGFu ZCBvdGhlci BjYW5jZXJz IGJhc2VsLC AxOSBtYXkg MjAyNiAtIH JvY2hlIChz aXg6IHJvLC Byb3A7IG90 Y3F4OiByaG hieSkgd2ls bCBwcmVzZW 50IG5ldyBk YXRhIGZyb2 0gbmluZSBh cHByb3ZlZC BhbmQgaW52 ZXN0aWdhdG lvbmFsIG1l ZGljaW5lcy BhY3Jvc3Mg bW9yZSB0aG FuIDE1IGlu ZGljYXRpb2 5zIGF0IHRo ZSAyMDI2IG FtZXJpY2Fu IHNvY2lldH kgb2YgY2xp bmljYWwgb2 5jb2xvZ3kg KGFzY28pIG FubnVhbCBt ZWV0aW5nLC BoZWxkIDI5 IG1heSB0by AyIGp1bmUg aW4gY2hpY2 Fnby4=
|
| 2026-05-15 12:45:00 |
RmRhIEFwcH JvdmVzIEdl bmVudGVjaO KAmXMgVGVj ZW50cmlxIE ZvciBBZGp1 dmFudCBNdX NjbGUtaW52 YXNpdmUgQm xhZGRlciBD YW5jZXIgV2 l0aCBDdGRu YS1ndWlkZW QgVHJlYXRt ZW50
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb3 A7IG90Y3F4 OiByaGhieS ksIGFubm91 bmNlZCB0b2 RheSB0aGF0 IHRoZSB1Ln MuIGZvb2Qg YW5kIGRydW cgYWRtaW5p c3RyYXRpb2 4gKGZkYSkg aGFzIGFwcH JvdmVkIHRl Y2VudHJpcc KuIChhdGV6 b2xpenVtYW IpIGFuZCB0 ZWNlbnRyaX EgaHlicmV6 YcKuIChhdG V6b2xpenVt YWIgYW5kIG h5YWx1cm9u aWRhc2UtdH FqcykgYXMg YW4gYWRqdX ZhbnQgdHJl YXRtZW50IG ZvciBhZHVs dCBwYXRpZW 50cyB3aXRo IG11c2NsZS 1pbnZhc2l2 ZSBibGFkZG VyIGNhbmNl ciAobWliYy kgd2hvIGhh dmUgY2lyY3 VsYXRpbmcg dHVtb3IgZG 5hIG1vbGVj dWxhciByZX NpZHVhbCBk aXNlYXNlIC hjdGRuYSBt cmQpIGFmdG VyIGN5c3Rl Y3RvbXksIG FzIGlkZW50 aWZpZWQgYn kgbmF0ZXJh 4oCZcyBzaW duYXRlcmHi hKIgY2R4IH Blci4=
|
| 2026-05-07 01:00:00 |
Um9jaGUgRW 50ZXJzIElu dG8gQSBEZW Zpbml0aXZl IE1lcmdlci BBZ3JlZW1l bnQgVG8gQW NxdWlyZSBQ YXRoYWkgVG 8gVHJhbnNm b3JtIEFpLW RyaXZlbiBE aWFnbm9zdG ljcw==
UGF0aGFp4o CZcyBiZXN0 LWluLWNsYX NzIGltYWdl IG1hbmFnZW 1lbnQgc3lz dGVtIChpbX MpIHdpdGgg YWR2YW5jZW QgYWkgYW5h bHlzaXMgYW 5kIHdvcmtm bG93IGNhcG FiaWxpdGll cyB3aWxsIG NvbXBsZW1l bnQgcm9jaG XigJlzIGRp Z2l0YWwgcG F0aG9sb2d5 IHBvcnRmb2 xpbyB0byBk cml2ZSBsYW JvcmF0b3J5 IGVmZmljaW VuY3ljb21i aW5pbmcgcm 9jaGXigJlz IHN0cm9uZy Bwb3NpdGlv biBpbiBjb2 1wYW5pb24g ZGlhZ25vc3 RpY3MgYW5k IHBhdGhhae KAmXMgYWR2 YW5jZWQgYW kgcGxhdGZv cm0gaGVscH MgYWNjZWxl cmF0ZSBjbG luaWNhbCB0 aGVyYXB5IG RldmVsb3Bt ZW50LCBmb3 N0ZXIgdGhl IGRpc2Nvdm VyeSBvZiBu ZXcgYmlvbW Fya2VycyBh bmQgY3JlYX RlIG5vdmVs IGRpYWdub3 N0aWMgdG9v bHN0aGVzZS BpbnRlZ3Jh dGVkIGNhcG FiaWxpdGll cyB3aWxsIG FjY2VsZXJh dGUgdGhlIH NoaWZ0IGZy b20gYnJvYW QgaW50ZXJ2 ZW50aW9uIH Rvd2FyZCBw ZXJzb25hbG lzZWQgaGVh bHRoY2FyZS Bmb3IgcGF0 aWVudHMgYm FzZWwsIDcg bWF5IDIwMj YgLSByb2No ZSAoc2l4Oi Bybywgcm9w OyBvdGNxeD ogcmhoYnkp IGFubm91bm NlZCB0b2Rh eSB0aGF0IG l0IGhhcyBl bnRlcmVkIG ludG8gYSBk ZWZpbml0aX ZlIG1lcmdl ciBhZ3JlZW 1lbnQgdG8g YWNxdWlyZS BwYXRoYWks IGEgdXMtYm FzZWQgY29t cGFueSBpbi BkaWdpdGFs IHBhdGhvbG 9neSBhbmQg YWktcG93ZX JlZCB0ZWNo bm9sb2d5IG ZvciBwYXRo b2xvZ3kgbG Fib3JhdG9y aWVzIGFuZC B0aGUgYmlv cGhhcm1hIG luZHVzdHJ5 Lg==
|
| 2026-04-30 01:00:00 |
R2VuZW50ZW NoIFRvIFBy ZXNlbnQgRX h0ZW5zaXZl IERhdGEgU2 hvd2Nhc2lu ZyBJdHMgSW 5kdXN0cnkt bGVhZGluZy BPcGh0aGFs bW9sb2d5IF BvcnRmb2xp byBBdCBBcn ZvIDIwMjY=
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb3 A7IG90Y3F4 OiByaGhieS ksIGFubm91 bmNlZCB0b2 RheSB0aGF0 IGl0IHdpbG wgc2hvd2Nh c2Uga2V5IH JlYWwtd29y bGQsIHByb2 R1Y3QgYW5k IHBpcGVsaW 5lIGRhdGEg ZnJvbSBpdH Mgb3BodGhh bG1vbG9neS Bwb3J0Zm9s aW8gYXQgdG hlIGFzc29j aWF0aW9uIG ZvciByZXNl YXJjaCBpbi B2aXNpb24g YW5kIG9waH RoYWxtb2xv Z3kgKGFydm 8pIGFubnVh bCBtZWV0aW 5nLCBoZWxk IG1heSAzLT cgaW4gZGVu dmVyLiB0aG UgZGF0YSBi ZWluZyBwcm VzZW50ZWQg ZW1waGFzaX plIGdlbmVu dGVjaOKAmX MgZm9jdXMg b24gcHJlc2 VydmluZyB2 aXNpb24gdG hyb3VnaCBp bm5vdmF0aX ZlIHRoZXJh cGllcywgaW 5jbHVkaW5n IHZhYnlzbW /CriAoZmFy aWNpbWFiLX N2b2EpLCBz dXN2aW1vwq 4gKHJhbmli aXp1bWFiIG ku
|
| 2026-04-29 13:01:00 |
WmVhbGFuZC BQaGFybWEg QW5kIFJvY2 hlIFRvIEFk dmFuY2UgUG V0cmVsaW50 aWRlLCBBbi BBbXlsaW4g QW5hbG9nLC BUbyBQaGFz ZSAzIFRyaW FscyBGb3Ig Q2hyb25pYy BXZWlnaHQg TWFuYWdlbW VudA==
Q29tcGFueS Bhbm5vdW5j ZW1lbnQg4o CTIG5vLiAx MSAvIDIwMj YgemVhbGFu ZCBwaGFybW EgYW5kIHJv Y2hlIHRvIG FkdmFuY2Ug cGV0cmVsaW 50aWRlLCBh biBhbXlsaW 4gYW5hbG9n LCB0byBwaG FzZSAzIHRy aWFscyBmb3 IgY2hyb25p YyB3ZWlnaH QgbWFuYWdl bWVudCBwaG FzZSAzIHRy aWFscyBmb3 IgY2hyb25p YyB3ZWlnaH QgbWFuYWdl bWVudCBwbG FubmVkIGZv ciBpbml0aW F0aW9uIGlu IHRoZSBzZW NvbmQgaGFs ZiBvZiAyMD I2IHBldHJl bGludGlkZS BkZW1vbnN0 cmF0ZWQgZG 91YmxlLWRp Z2l0IHdlaW dodCBsb3Nz IHdpdGggcG xhY2Viby1s aWtlIHRvbG VyYWJpbGl0 eSBpbiB0aG UgenVwcmVt ZS0xIHBoYX NlIDIgdHJp YWwgemVhbG FuZCBwaGFy bWEgYW5kIH JvY2hlIGFp bSB0byB1bm xvY2sgdGhl IGZ1bGwgdm FsdWUgcG90 ZW50aWFsIG 9mIHBldHJl bGludGlkZS Bwcm92aWRp bmcgYSBoaW dobHkgdG9s ZXJhYmxlIG 9wdGlvbiBm b3IgcGVvcG xlIGxpdmlu ZyB3aXRoIG 92ZXJ3ZWln aHQgYW5kIG 9iZXNpdHkg Y29wZW5oYW dlbiwgZGVu bWFyaywgYX ByaWwgMjks IDIwMjYg4o CTIHplYWxh bmQgcGhhcm 1hIGEvcyAo bmFzZGFxOi B6ZWFsKSAo Y3ZyLW5vLg ==
|
| 2026-04-24 08:00:00 |
R2VuZW50ZW NoIFBhcnRu ZXJzIFdpdG ggQ29tZWR5 IEljb24gRG Ftb24gV2F5 YW5zIEFuZC BEaWF0cmli ZSBUbyBBZG RyZXNzIERp YWJldGVzLX JlbGF0ZWQg VmlzaW9uIE xvc3MgV2l0 aCDigJhhbG wgRXllcyBP biBEbWXigJ kgQ2FtcGFp Z24=
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb3 A7IG90Y3F4 OiByaGhieS ksIGFubm91 bmNlZCB0aG UgbGF1bmNo IG9mIGFsbC BleWVzIG9u IGRtZSwgYS BjYW1wYWln biBkZXZlbG 9wZWQgaW4g cGFydG5lcn NoaXAgd2l0 aCBhZHZvY2 FjeSBncm91 cCwgZGlhdH JpYmUsIHRo YXQgaGFybm Vzc2VzIHRo ZSBwb3dlci BvZiBodW1v ciB0byBkZX N0aWdtYXRp emUgYW5kIG JyaW5nIGF0 dGVudGlvbi B0byBkaWFi ZXRlcy1yZW xhdGVkIHZp c2lvbiBjb2 5kaXRpb25z LiB0aGUgbX VsdGktY2hh bm5lbCBjYW 1wYWlnbiBm ZWF0dXJlcy BkYW1vbiB3 YXlhbnPigJ kgaWNvbmlj IGh1bW9yIG FuZCBwZXJz b25hbCBkaW FiZXRlcyBq b3VybmV5LC BhcyB3ZWxs IGFzIHBhdG llbnQgcGVy c3BlY3Rpdm VzIHRvIGNy ZWF0ZSBhIH Bvd2VyZnVs IGN1bHR1cm FsIGNvbm5l Y3Rpb24u
|
| 2026-04-23 01:00:00 |
W2FkIEhvYy BBbm5vdW5j ZW1lbnQgUH Vyc3VhbnQg VG8gQXJ0Li A1MyBMcl0g Um9jaGUgUm Vwb3J0cyBT dHJvbmcgU2 FsZXMgR3Jv d3RoIE9mIC s2JSBBdCBD b25zdGFudC BFeGNoYW5n ZSBSYXRlcy BJbiBUaGUg Rmlyc3QgUX VhcnRlciBP ZiAyMDI2Oy AtNSUgSW4g Q2hmIER1ZS BUbyBUaGUg U2lnbmlmaW NhbnQgQXBw cmVjaWF0aW 9uIE9mIFRo ZSBTd2lzcy BGcmFuYw==
R3JvdXAgc2 FsZXPCoHdl cmUgKzYlIG F0IGNvbnN0 YW50IGV4Y2 hhbmdlIHJh dGVzIChjZX IpMSwgLTUl IHdoZW4gcm Vwb3J0ZWQg aW4gY2hmIG FuZCArOSUg aW4gdXNkMi wgaW4gdGhl IGZpcnN0IH RocmVlIG1v bnRocywgZH JpdmVuIGJ5 IGhpZ2ggZG VtYW5kIGZv ciBvdXIgaW 5ub3ZhdGl2 ZSBtZWRpY2 luZXMgYW5k IGRpYWdub3 N0aWNzLiBw aGFybWFjZX V0aWNhbHMg ZGl2aXNpb2 4gc2FsZXMg d2VyZSArNy UgYXQgY2Vy LCAtNCUgd2 hlbiByZXBv cnRlZCBpbi BjaGYgYW5k ICsxMCUgaW 4gdXNkLCBk dWUgdG8gY2 9udGludWVk IGhpZ2ggZ3 Jvd3RoIGlu IHNhbGVzIG 9mIG1lZGlj aW5lcyBmb3 IgdGhlIHRy ZWF0bWVudC BvZiBzZXZl cmUgZGlzZW FzZXM7IHhv bGFpciAoY2 hyb25pYyBo aXZlcywgZm 9vZCBhbGxl cmdpZXMpLC BwaGVzZ28g KGJyZWFzdC BjYW5jZXIp LCBoZW1saW JyYSAoaGFl bW9waGlsaW EgYSksIHZh YnlzbW8gKH NldmVyZSBl eWUgZGlzZW FzZXMpIGFu ZCBvY3Jldn VzIChtdWx0 aXBsZSBzY2 xlcm9zaXMp IHdlcmUgdG hlIHRvcCBn cm93dGggZH JpdmVycy4=
|
| 2026-04-21 19:15:00 |
R2VuZW50ZW No4oCZcyBG ZW5lYnJ1dG luaWIgU2ln bmlmaWNhbn RseSBSZWR1 Y2VkIFJlbG Fwc2VzIFZl cnN1cyBTdG FuZGFyZCBP ZiBDYXJlIF RvIEFwcHJv eGltYXRlbH kgT25lIEV2 ZXJ5IDE3IF llYXJzIElu IFJtcw==
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb3 A7IG90Y3F4 OiByaGhieS ksIGFubm91 bmNlZCB0b2 RheSBuZXcg ZGF0YSBmcm 9tIHRoZSBw b3NpdGl2ZS BwaGFzZSBp aWkgZmVuaG FuY2UgMSBh bmQgMiBzdH VkaWVzLCB3 aGljaCBtZX QgdGhlaXIg cHJpbWFyeS BlbmRwb2lu dC4gdGhlIH N0dWRpZXMg c2hvd2VkIH RoYXQgZmVu ZWJydXRpbm liLCBhbiBp bnZlc3RpZ2 F0aW9uYWwg bm9uLWNvdm FsZW50IGJy dXRvbuKAmX MgdHlyb3Np bmUga2luYX NlIChidGsp IGluaGliaX RvciwgcmVk dWNlZCB0aG UgYW5udWFs aXplZCByZW xhcHNlIHJh dGUgKGFyci kgYnkgNTEu MSUgKHA=
|
